PABPC1 and atherosclerosis: Furthermore, Lin et al. observed elevated serum poly(A)-binding protein cytoplasmic 1 levels in patients with atherosclerosis-related transient ischemic attacks, and this marker increases the risk of mortality in patients with several cancer types [35].